Posted by Clinical Lab Products | Feb 9, 2004 | Miscellaneous |
The FDA has granted marketing clearance for sexually transmitted disease testing on the Gen-Probe TIGRIS® DTS™ System, a fully automated, high-throughput instrument for the molecular diagnostics marketplace. The TIGRIS® System has been approv
Read MorePosted by Clinical Lab Products | Feb 5, 2004 | Miscellaneous |
By Gary L. Milburn, PhD The clinical laboratory diagnostic field is undergoing major change. The available technologies are rapidly changing, improving, and becoming more complex, and there is increasing financial pressure on l
Read MorePosted by Clinical Lab Products | Feb 1, 2004 | Cancer, Hematology & Serology, Hematology Instrumentation |
By Nicholas Borgert Advances in hematologic disease testing are giving physicians the comprehensive information they need for more effective treatment protocols for those diagnosed with blood disorders. Over the past 40 years, refinements in te
Read MorePosted by Clinical Lab Products | Jan 10, 2004 | Cancer, Miscellaneous |
ASH Meeting Addresses Developments in Treating Blood Disorders Approximately 20,000 physicians and scientists from around the world gathered for the 45th Annual Meeting of the American Society of Hematology (ASH), December 6–9, 2003, at the S
Read MorePosted by Clinical Lab Products | Jan 5, 2004 | Miscellaneous |
By Robert Janetschek, MSc, MT (ASCP) & RS Greenfield, PhD Formation of blood clots (thrombi) that block arteries or veins is a life-threatening event that can result in severe medical consequences including myocardial infarction, stroke, and
Read More